AbbVie is a global, research-based biopharmaceutical company that was established in 2013, following its separation from Abbott Laboratories. This distinguished biopharmaceutical giant is deeply committed to utilizing its pool of distinctive and varied expertise, collaborating with healthcare stakeholders, and leveraging cutting-edge technology to advance science and improve health outcomes.
AbbVie’s business model is focused on creating and developing advanced therapies that have the potential to significantly improve patients' lives. The company's portfolio is comprised of highly valuable assets including several market-leading drugs, which speak volumes about the company's robust research and development capabilities. Additionally, AbbVie has a strong pipeline of promising new drugs in development across important therapeutic areas including immunology, oncology, neuroscience, and virology.